Fungal Infection: Clinical Trials

13 trials for Fungal Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 3 unknown, 1 recruiting, 1 withdrawn. 13 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 213Completed 8, Unknown 3, Recruiting 1, Withdrawn 1
Phase 11Withdrawn 1

Follow Fungal Infection: new trials by email Literature Review of Fungal Infection trials Research Report on Fungal Infection

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
genotype-directed dosing with dosing software based on therapeutic drug monitoring - Fungal Infection, Haematological Malignancy
Phase 2RecruitingThe University of Queensland1042025-04-142026-04-16
A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail
BB2603-1, BB2603-3, BB2603-10 - Distal Subungual Onychomycosis, Fungal Infection
Phase 2CompletedBlueberry Therapeutics1112021-03-222023-08-01
Escalation Antifungal Prophylaxis for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Escalating prophylaxis - Fungal Infection
Phase 2UnknownShanghai Jiao Tong University School of Medicine1752020-01-152021-11-26
Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin
Caspofungin - Fungal Infection
Phase 2CompletedCttq322018-09-172021-07-07
Universal Prophylaxis Versus Pre-emptive Therapy With Posaconazole Post-Lung Transplant
Universal Posaconazole Prophylaxis, Pre-emptive Posaconazole Therapy - Fungal Infection
Phase 2UnknownBayside Health1402018-07-022018-06-19
Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole
Conditioning treatment "Thiotepa-Treosulfan-Fludarabine", PBSC graft, GvHD prophylaxis - Transplant-Related Hematologic Malignancy, Leukemia, Acute
Phase 2CompletedCiceri Fabio102018-06-182022-07-19
Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients
Posaconazole - Aplastic Anemia, Myelodysplastic Syndromes
Phase 2CompletedSeoul National University Hospital202018-04-202024-12-20
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension
CD101, Caspofungin, Fluconazole - Candidemia, Mycoses
Phase 2CompletedCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2072016-07-262020-12-08
Pharmacokinetic, Safety and Efficacy of Intermittent Application of Caspofungin for Antifungal Prophylaxis
caspofungin - Fungal Infection
Phase 2CompletedWerner J. Heinz252011-04-012014-01-09
Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia
Posaconazole - Leukemia, Fungal Infection
Phase 2CompletedM.D. Anderson Cancer Center252009-09-012019-02-27
Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients
human lactoferrin (hLF1-11) - Fungal Infection, Bacterial Infection
Phase 1 / Phase 2WithdrawnAM-Pharma2008-11-012015-06-30
Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042)
caspofungin acetate - Fungal Infection
Phase 2CompletedMerck Sharp & Dohme LLC162004-05-012017-02-23
Prophylaxis With Caspofungin in High-Risk Liver Transplantation
Caspofungin - Liver Transplantation, Fungal Infection
Phase 2UnknownGrupo de Estudio de Infecciones en Transplantados702003-10-012007-04-13

Narrower conditions

Mycoses (13)  ·  Infections (2)  ·  Leukemia (2)  ·  Myelodysplastic Syndromes (2)  ·  Anemia, Aplastic (1)  ·  Aspergillosis (1)  ·  Bacterial Infections (1)  ·  Bone Marrow Neoplasms (1)  ·  Candidemia (1)  ·  Candidiasis, Invasive (1)  ·  Communicable Diseases (1)  ·  Fungemia (1)  ·  Graft vs Host Disease (1)  ·  Hematologic Neoplasms (1)  ·  Invasive Fungal Infections (1)

Broader conditions

Bacterial Infections and Mycoses (13)  ·  Infections (11)  ·  Hematologic Diseases (5)  ·  Hemic and Lymphatic Diseases (5)  ·  Bone Marrow Diseases (3)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Agranulocytosis (1)  ·  Anemia (1)  ·  Bone Marrow Failure Disorders (1)  ·  Candidiasis (1)  ·  Cytopenia (1)

Interventions

Caspofungin (5)  ·  posaconazole (2)  ·  Fluconazole (1)  ·  Injections (1)

Sponsors

AM-Pharma (1)  ·  Bayside Health (1)  ·  Blueberry Therapeutics (1)  ·  Ciceri Fabio (1)  ·  Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1)  ·  Cttq (1)  ·  Grupo de Estudio de Infecciones en Transplantados (1)  ·  M.D. Anderson Cancer Center (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Seoul National University Hospital (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  The University of Queensland (1)  ·  Werner J. Heinz (1)

Countries

United States (3)  ·  Australia (2)  ·  China (2)  ·  Germany (2)  ·  Italy (2)  ·  Spain (2)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Czechia (1)  ·  Greece (1)  ·  Hungary (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Romania (1)

Top investigators

Jason A Roberts, PhD (1)  ·  Jesus Fortun, MD (1)  ·  Jianda Hu, Ph.D (1)  ·  Jiong Hu (1)  ·  Jorge Cortes, MD (1)  ·  Orla Morrissey (1)  ·  Peter J Donnelly, PhD (1)  ·  Taylor Sandison, MD MPH (1)  ·  Werner J Heinz, MD (1)

Results publications

PMID 32955088, PMID 38008099, PMID 38502709, PMID 39468640, PMID 39529079, PMID 41940006

NIH funding

2009 (1), 2015 (1), 2017 (1)